{"database": "lobbying", "table": "lobbying_activities", "rows": [[3043967, "fae55b4d-c123-4c40-86d6-d1acc71dbf10", "Q3", "HELIX, INC.", 401106164, "HELIX, INC.", 2023, "third_quarter", "HCR", "US H 1526 Medicare Hereditary Cancer USH2369 In Vitro Tests US S 765 Hereditary Cancer Genetic Testing Pharmacogenomic testing, insurance coverage opportunities for whole exome sequencing and specific testing for genetic diseases, opportunities to use genetic testing to justify insurance coverage for specific treatments", "HOUSE OF REPRESENTATIVES,SENATE", null, 90000, 0, 0, "2023-10-02T11:10:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3043967"], "units": {}, "query_ms": 8.14300391357392, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}